Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy

This study is testing a nurse-led, app-based program called "virtual diabetes care" for adults with Type 2 Diabetes who are on Medicaid and use insulin. This program uses MyChart messaging for education, phone calls with nurses to help solve problems, and the mySugr app to track your blood sugar and help adjust your treatment. The goal is to see if this program can improve how well you manage your diabetes, specifically by looking at your A1C (a measure of average blood sugar over 2-3 months) and how often your blood sugar is in a healthy range. You might be able to join if you are 18 to 90 years old, have Type 2 Diabetes, use insulin, have Medicaid, and own a smartphone. The study aims to enroll 60 participants, but its current recruitment status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 60 participants.
What's involved
You would participate in a 12-month program involving app-based education, phone calls with nurses, and remote monitoring through the mySugr app. Your A1C and blood glucose levels will be measured at baseline, 3, 6, 9, and 12 months.
Compensation
Not stated in the trial record.
Follow-up
You will be followed for 12 months after starting the program.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06814184

Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy

Recruiting
NAAges 18–90InterventionalHealth services
Rutgers, The State University of New Jersey
~60 participants
Updated 2026-07-02 on ClinicalTrials.gov
What's tested:app-based nurse-led virtual diabetes care

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Glycemic control: glycated hemoglobin AIC
Measured over baseline, 3, 6, 9, and 12 months
+2 more outcomes measured
Type 2 Diabetes
2 sites across 1 states
New Jersey2
  • Helen NC Chen, PhD · PRINCIPAL_INVESTIGATOR · Rutgers School of Nursing

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

A1C \>7 for age 18-64, A1C\>8 for age 65 or older within 12 months prior baseline
A1C\>7 for age 18-64, A1c\>8 for age 65 or older at baseline
Medicaid recipient or dual Medicaid and Medicare recipient
Age 18 or older
Type 2 diabetes
On insulin therapy
Owning and using Android or iOS smartphone for at least 6 months
English proficiency
Adequate vision to read text messages on their current smartphone
Smartphone use proficiency. Smartphone proficiency will be self-reported and determined by telephone as the ability to use a smartphone in ways other than emailing, texting, and making phone calls.

Exclusion

Pregnancy
Patients with cognitive impairment who will be screened with the Six-Item Screener to Identify Cognitive Impairment Among Potential Research Subjects.
  • Glycemic control: glycated hemoglobin AICbaseline, 3, 6, 9, and 12 months

    Electronic health record extracted lab test drawn at baseline, 3, 6, 9, and 12 months

  • Glycemic control - the rate of pre-prandial blood glucose readings in target rangebaseline, 3, 6, 9, and 12 months

    Home monitoring glucometer at baseline and diabetes app report containing blood glucose readings at home for 3, 6, 9, and 12 months. It is calculated from the number of BG that met the target divided by the total number of BG tested.

  • Glycemic control - the rate of peak postprandial blood glucose reading in target rangebaseline, 3, 6, 9, and 12 months

    Blood glucose reading obtained from patient's home monitoring glucometer at baseline and diabetes app report containing blood glucose readings at home for 3, 6, 9, and 12 months. It is calculated from the number of BG that met the target divided by the total number of BG tested.